BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35005813)

  • 1. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
    Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
    J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.
    Marks RM; Ryan A; Heba ER; Tang A; Wolfson TJ; Gamst AC; Sirlin CB; Bashir MR
    AJR Am J Roentgenol; 2015 Mar; 204(3):527-35. PubMed ID: 25714281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment.
    Jeon SK; Lee DH; Hur BY; Park SJ; Kim SW; Park J; Suh KS; Lee KW; Yi NJ; Han JK
    J Magn Reson Imaging; 2023 Nov; 58(5):1375-1383. PubMed ID: 36825827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.
    Lee KH; Lee JM; Park JH; Kim JH; Park HS; Yu MH; Yoon JH; Han JK; Choi BI
    Korean J Radiol; 2013; 14(6):894-904. PubMed ID: 24265564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Bannas P; Bookwalter CA; Ziemlewicz T; Motosugi U; Munoz Del Rio A; Potretzke TA; Nagle SK; Reeder SB
    Eur Radiol; 2017 Jan; 27(1):32-40. PubMed ID: 27137648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Eur J Radiol; 2010 Jan; 73(1):131-6. PubMed ID: 18996659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
    Kim YK; Lee MW; Lee WJ; Kim SH; Rhim H; Lim JH; Choi D; Kim YS; Jang KM; Lee SJ; Lim HK
    Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abbreviated Gadoxetic Acid-enhanced MRI with Second-Shot Arterial Phase Imaging for Liver Metastasis Evaluation.
    Kim JW; Lee CH; Park YS; Lee J; Kim KA
    Radiol Imaging Cancer; 2019 Sep; 1(1):e190006. PubMed ID: 33778670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a deep learning algorithm for three-dimensional T1-weighted gradient-echo imaging of gadoxetic acid-enhanced MRI in patients at a high risk of hepatocellular carcinoma.
    Kim JH; Yoon JH; Kim SW; Park J; Bae SH; Lee JM
    Abdom Radiol (NY); 2024 Mar; 49(3):738-747. PubMed ID: 38095685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
    Canellas R; Patel MJ; Agarwal S; Sahani DV
    Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of abbreviated gadoxetic acid-enhanced magnetic resonance protocols with contrast-enhanced computed tomography for detection of colorectal liver metastases.
    Ozaki K; Ishida S; Higuchi S; Sakai T; Kitano A; Takata K; Kinoshita K; Matta Y; Ohtani T; Kimura H; Gabata T
    World J Radiol; 2022 Oct; 14(10):352-366. PubMed ID: 36340439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of gadoxetic acid-enhanced abbreviated magnetic resonance imaging protocol in small hepatocellular carcinoma (≤2 cm) in high-risk patients.
    Wang JH; Qiu QS; Dong SY; Chen XS; Wang WT; Yang YT; Sun W; Rao SX
    Acta Radiol; 2023 Oct; 64(10):2687-2696. PubMed ID: 37691270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging.
    Takayama Y; Nishie A; Okamoto D; Fujita N; Asayama Y; Ushijima Y; Yoshizumi T; Yoneyama M; Ishigami K
    Magn Reson Med Sci; 2022 Jul; 21(3):445-457. PubMed ID: 33883364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.